BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 31484669)

  • 1. Clonal Mutations Activate the NF-κB Pathway to Promote Recurrence of Nasopharyngeal Carcinoma.
    You R; Liu YP; Lin DC; Li Q; Yu T; Zou X; Lin M; Zhang XL; He GP; Yang Q; Zhang YN; Xie YL; Jiang R; Wu CY; Zhang C; Cui C; Wang JQ; Wang Y; Zhuang AH; Guo GF; Hua YJ; Sun R; Yun JP; Zuo ZX; Liu ZX; Zhu XF; Kang TB; Qian CN; Mai HQ; Sun Y; Zeng MS; Feng L; Zeng YX; Chen MY
    Cancer Res; 2019 Dec; 79(23):5930-5943. PubMed ID: 31484669
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Down-regulation of succinate dehydrogenase subunit B and up-regulation of pyruvate dehydrogenase kinase 1 predicts poor prognosis in recurrent nasopharyngeal carcinoma.
    Dai Z; Pan S; Chen C; Cao L; Li X; Chen X; Su X; Lin S
    Tumour Biol; 2016 Apr; 37(4):5145-52. PubMed ID: 26547584
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular markers to assess short-term disease local recurrence in nasopharyngeal carcinoma.
    Xu T; Su B; Wang C; Wang S; Huang H; Pan Y; Wang D; Wei W; Claret FX; Yang H
    Oncol Rep; 2015 Mar; 33(3):1418-26. PubMed ID: 25607111
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exome and genome sequencing of nasopharynx cancer identifies NF-κB pathway activating mutations.
    Li YY; Chung GT; Lui VW; To KF; Ma BB; Chow C; Woo JK; Yip KY; Seo J; Hui EP; Mak MK; Rusan M; Chau NG; Or YY; Law MH; Law PP; Liu ZW; Ngan HL; Hau PM; Verhoeft KR; Poon PH; Yoo SK; Shin JY; Lee SD; Lun SW; Jia L; Chan AW; Chan JY; Lai PB; Fung CY; Hung ST; Wang L; Chang AM; Chiosea SI; Hedberg ML; Tsao SW; van Hasselt AC; Chan AT; Grandis JR; Hammerman PS; Lo KW
    Nat Commun; 2017 Jan; 8():14121. PubMed ID: 28098136
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Constitutive activation of distinct NF-κB signals in EBV-associated nasopharyngeal carcinoma.
    Chung GT; Lou WP; Chow C; To KF; Choy KW; Leung AW; Tong CY; Yuen JW; Ko CW; Yip TT; Busson P; Lo KW
    J Pathol; 2013 Nov; 231(3):311-22. PubMed ID: 23868181
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Protein microarray analysis on changes in protein phosphorylation in recurrent nasopharyngeal carcinoma].
    Su HF; Zhang XB; Fang M; He QC; Li WF; Wu SX
    Zhonghua Yi Xue Za Zhi; 2011 Dec; 91(45):3219-22. PubMed ID: 22333108
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Whole-exome sequencing identifies multiple loss-of-function mutations of NF-κB pathway regulators in nasopharyngeal carcinoma.
    Zheng H; Dai W; Cheung AK; Ko JM; Kan R; Wong BW; Leong MM; Deng M; Kwok TC; Chan JY; Kwong DL; Lee AW; Ng WT; Ngan RK; Yau CC; Tung S; Lee VH; Lam KO; Kwan CK; Li WS; Yau S; Chan KW; Lung ML
    Proc Natl Acad Sci U S A; 2016 Oct; 113(40):11283-11288. PubMed ID: 27647909
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular characteristics of pediatric nasopharyngeal carcinoma using whole-exome sequencing.
    Wu B; Shen L; Peng G; Li Y; Zhou Z; Li J; Huang X; Zhou Q; Jiang H; Huang J; Ding Q; Zhang Z; Qin Y; Hong X; Shi L; Zou Z; Yao J; Zhang J; Liu D; Wan C; Wu G; Song L; Chen S; Yi J; Yang K
    Oral Oncol; 2022 Dec; 135():106218. PubMed ID: 36332446
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clonal Selection Drives NF-κB Activation in Recurrent Nasopharyngeal Carcinoma.
    Sehgal K; Barbie DA
    Cancer Res; 2019 Dec; 79(23):5915-5916. PubMed ID: 31791959
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SPLUNC1 reduces the inflammatory response of nasopharyngeal carcinoma cells infected with the EB virus by inhibiting the TLR9/NF-κB pathway.
    Ou C; Sun Z; Zhang H; Xiong W; Ma J; Zhou M; Lu J; Zeng Z; Bo X; Chen P; Li G; Li X; Li X
    Oncol Rep; 2015 Jun; 33(6):2779-88. PubMed ID: 25891128
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rediscovery of NF-κB signaling in nasopharyngeal carcinoma: How genetic defects of NF-κB pathway interplay with EBV in driving oncogenesis?
    Yi M; Cai J; Li J; Chen S; Zeng Z; Peng Q; Ban Y; Zhou Y; Li X; Xiong W; Li G; Xiang B
    J Cell Physiol; 2018 Aug; 233(8):5537-5549. PubMed ID: 29266238
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulatory role of CDX2 and NOX4 expression associated with recurrent nasopharyngeal carcinoma.
    Chen G; Hao H; Ai JW
    Eur Rev Med Pharmacol Sci; 2018 Jan; 22(2):450-455. PubMed ID: 29424902
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Identification of differentially expressed genes in recurrent nasopharyngeal carcinoma and analysis of their chromosomal location].
    Huang ZX; Li WF; Lin S; Huang Y; DU JM; Tan YX; Fang XB; Zhang CH; Fang WQ; Liao ZS
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2010 Jan; 45(1):47-51. PubMed ID: 20398539
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of CALM as the potential serum biomarker for predicting the recurrence of nasopharyngeal carcinoma using a mass spectrometry-based comparative proteomic approach.
    Meng H; Zhu X; Li L; Liang Z; Li X; Pan X; Zeng F; Qu S
    Int J Mol Med; 2017 Oct; 40(4):1152-1164. PubMed ID: 28849027
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ikappa B kinase alpha involvement in the development of nasopharyngeal carcinoma through a NF-κB-independent and ERK-dependent pathway.
    Xie Y; Li Y; Peng X; Henderson F; Deng L; Chen N
    Oral Oncol; 2013 Dec; 49(12):1113-20. PubMed ID: 24075781
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NF-κB Signaling Regulates Expression of Epstein-Barr Virus BART MicroRNAs and Long Noncoding RNAs in Nasopharyngeal Carcinoma.
    Verhoeven RJ; Tong S; Zhang G; Zong J; Chen Y; Jin DY; Chen MR; Pan J; Chen H
    J Virol; 2016 Jul; 90(14):6475-88. PubMed ID: 27147748
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IKBB tumor suppressive role in nasopharyngeal carcinoma via NF-κB-mediated signalling.
    Phoon YP; Cheung AK; Cheung FM; Chan KF; Wong S; Wong BW; Tung SY; Yau CC; Ng WT; Lung ML
    Int J Cancer; 2016 Jan; 138(1):160-70. PubMed ID: 26227166
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Low expression of succinate dehydrogenase subunit B in locally recurrent nasopharyngeal carcinoma and implication for prognosis].
    Lin S; Dai Z; Chen C; Pan S; Liao Z
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2015 Jan; 50(1):38-42. PubMed ID: 25764926
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epstein-Barr virus-coded miR-BART13 promotes nasopharyngeal carcinoma cell growth and metastasis via targeting of the NKIRAS2/NF-κB pathway.
    Xu YJ; Zhou R; Zong JF; Lin WS; Tong S; Guo QJ; Lin C; Lin SJ; Chen YX; Chen MR; Chen HL; Ye YB; Pan JJ
    Cancer Lett; 2019 Apr; 447():33-40. PubMed ID: 30684592
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dissecting the heterogeneity of the microenvironment in primary and recurrent nasopharyngeal carcinomas using single-cell RNA sequencing.
    Peng WS; Zhou X; Yan WB; Li YJ; Du CR; Wang XS; Shen CY; Wang QF; Ying HM; Lu XG; Xu TT; Hu CS
    Oncoimmunology; 2022; 11(1):2026583. PubMed ID: 35096485
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.